Kidney care receives innovation boost
Pioneering solutions addressing the life-changing effects of
kidney failure are now underway thanks to a national funding
The 14 winners
have been announced today, as part of a £3.6m competition funded by
the Department of Health through the Small Business Research
Initiative and managed by the National Institute for Health
Research Devices for Dignity Healthcare Technology Co-operative
(NIHR Devices for Dignity HTC). One of the winners was IF Sensing
Ltd - a spin out company led by Dr Sandip Mitra and Professor Paul
Brenchley from Manchester Royal Infirmary, to fund a device for
monitoring renal function at home allowing out of hospital
monitoring of kidney function
The aim of the competition is to
help the 5,000 people diagnosed with kidney failure every year.
There are currently 41,000 patients in England receiving treatment
for kidney failure.
The loss of kidney function is a
life changing event that can result in life-long dependence on
healthcare for the patient. Innovations in earlier diagnosis of
kidney disease could reduce the number of affected individuals
while others can give patients with kidney failure greater
independence and enable treatment closer to home.
Although end-stage renal failure affects only 0.05% of the
general population it commands 1-2% of the annual NHS Budget.
Lord Howe, Health Minister, said:
"Innovation is essential for improving treatments and finding
new cures, so I am delighted that the NIHR Devices for Dignity HTC
is awarding these funds to help develop technologies that can
make a difference to patients suffering with kidney disease.
This will also build on Britain's reputation as a world leader in
science, research and development. I look forward to learning more
about the progress and success of this initiative now that these
winners have been announced."
Three of the 14 winners of the competition are
aimed at the prevention of Acute Kidney Injury (AKI). It is
estimated that 4.9% of hospital patients have AKI and severe cases
are associated with a 10-20% chance of death within one year.
Another of the projects funded will see the
development of a test for kidney disease progression in patients
with diabetes, the most common cause of kidney failure.
The remaining 10 successful projects aim to
improve patient independence and quality of life of people with
kidney disease. These projects spread across all areas of renal
medicine from pre-dialysis, haemodialysis and peritoneal dialysis
David Coyle, a patient who has suffered with kidney disease for
over 25 years, was a judge on the competition. David said: "I was
delighted to be asked to use my kidney patient knowledge and
experience as a judge on the D4D selection panel to identify
innovative ideas to use technology to benefit patients.
"The competition has produced some truly excellent technology
initiatives which, I believe, will greatly transform patient
welfare and facilitate greater independence. D4D has found a
winning formula to leverage technology for the benefit of patients
at every stage of renal disease."
To see the full list of winners visit the